Assessing treatment effect modification due to comorbidity using individual participant data from industry-sponsored drug trials
View ORCID ProfilePeter Hanlon, Elaine W Butterly, Anoop SV Shah, Laurie J Hannigan, Jim Lewsey, Frances S Mair, David Kent, Bruce Guthrie, View ORCID ProfileSarah H Wild, Nicky J Welton, Sofia Dias, David A McAllister
doi: https://doi.org/10.1101/2023.01.19.23284762
Peter Hanlon
1School for Health and Wellbeing, University of Glasgow
Elaine W Butterly
1School for Health and Wellbeing, University of Glasgow
Anoop SV Shah
2London School of Hygiene and Tropical Medicine
Laurie J Hannigan
3Nic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway
4Population Health Sciences, Bristol Medical School, University of Bristol
5Department of Mental Disorders, Norwegian Institute of Public Health
Jim Lewsey
1School for Health and Wellbeing, University of Glasgow
Frances S Mair
1School for Health and Wellbeing, University of Glasgow
David Kent
6Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center/Tufts University School of Medicine, Boston, Massachusetts
Bruce Guthrie
7Usher Institute, University of Edinburgh
Sarah H Wild
7Usher Institute, University of Edinburgh
Nicky J Welton
4Population Health Sciences, Bristol Medical School, University of Bristol
Sofia Dias
8Centre for Reviews and Dissemination, University of York
David A McAllister
1School for Health and Wellbeing, University of Glasgow
Article usage
Posted January 20, 2023.
Assessing treatment effect modification due to comorbidity using individual participant data from industry-sponsored drug trials
Peter Hanlon, Elaine W Butterly, Anoop SV Shah, Laurie J Hannigan, Jim Lewsey, Frances S Mair, David Kent, Bruce Guthrie, Sarah H Wild, Nicky J Welton, Sofia Dias, David A McAllister
medRxiv 2023.01.19.23284762; doi: https://doi.org/10.1101/2023.01.19.23284762
Assessing treatment effect modification due to comorbidity using individual participant data from industry-sponsored drug trials
Peter Hanlon, Elaine W Butterly, Anoop SV Shah, Laurie J Hannigan, Jim Lewsey, Frances S Mair, David Kent, Bruce Guthrie, Sarah H Wild, Nicky J Welton, Sofia Dias, David A McAllister
medRxiv 2023.01.19.23284762; doi: https://doi.org/10.1101/2023.01.19.23284762
Subject Area
Subject Areas
- Addiction Medicine (325)
- Allergy and Immunology (635)
- Anesthesia (168)
- Cardiovascular Medicine (2418)
- Dermatology (208)
- Emergency Medicine (382)
- Epidemiology (11831)
- Forensic Medicine (10)
- Gastroenterology (705)
- Genetic and Genomic Medicine (3792)
- Geriatric Medicine (353)
- Health Economics (641)
- Health Informatics (2426)
- Health Policy (943)
- Hematology (344)
- HIV/AIDS (795)
- Medical Education (372)
- Medical Ethics (105)
- Nephrology (404)
- Neurology (3548)
- Nursing (200)
- Nutrition (531)
- Oncology (1844)
- Ophthalmology (541)
- Orthopedics (223)
- Otolaryngology (287)
- Pain Medicine (234)
- Palliative Medicine (68)
- Pathology (450)
- Pediatrics (1045)
- Primary Care Research (425)
- Public and Global Health (6212)
- Radiology and Imaging (1302)
- Respiratory Medicine (839)
- Rheumatology (381)
- Sports Medicine (327)
- Surgery (409)
- Toxicology (51)
- Transplantation (174)
- Urology (148)